Silverback Therapeutics shares owned by GSA Capital Partners
Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by GSA Capital Partners
from 13F filings
Historical chart of GSA Capital Partners investment in Silverback Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silverback Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Silverback Therapeutics by GSA Capital Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $1.3M | 129k | 10.22 |
| 2023-12-31 | $632k | 115k | 5.48 |
| 2023-03-31 | $70k | 11k | 6.52 |
| 2022-03-31 | $80k | 23k | 3.49 |
| 2021-12-31 | $77k | 12k | 6.64 |